क्लोपिवस 300 एमजी टैबलेट 2's

Drug-Drug Interactions

Inform your doctor if you are taking any of the following medicines, as they may interact with Clopivas 300 mg Tablet:

• Blood Thinners and Anticoagulants: Medicines such as warfarin, apixaban, rivaroxaban, or heparin may increase the risk of bleeding when taken with Clopivas 300 mg Tablet.
• NSAIDs and Pain Relievers: Medicines such as ibuprofen, naproxen, or diclofenac may increase the risk of stomach irritation, ulcers, and bleeding.
• Certain Proton Pump Inhibitors: Medicines such as omeprazole and esomeprazole may reduce the effectiveness of Clopivas 300 mg Tablet by interfering with its activation in the liver.
• Selective Serotonin Reuptake Inhibitors (SSRIs): Antidepressants such as fluoxetine, sertraline, and paroxetine may increase the risk of bleeding when used together with Clopivas 300 mg Tablet.
• Aspirin: Aspirin may increase the risk of bleeding when combined with Clopivas 300 mg Tablet. However, some patients may be intentionally prescribed both medicines together under medical supervision.

Drug-Food Interactions

The following foods and beverages may interact with Clopivas 300 mg Tablet and affect its safety or effectiveness:

• Alcohol: Excessive alcohol consumption may increase the risk of stomach irritation and bleeding while taking Clopivas 300 mg Tablet.
• Grapefruit Products: The effect of grapefruit or grapefruit juice on Clopivas 300 mg Tablet is not fully established. Consult your doctor before making significant dietary changes involving grapefruit products while taking this medicine.

Drug-Disease Interactions

Inform your doctor if you have a history of the following conditions before taking Clopivas 300 mg Tablet, as it may worsen your condition or require additional monitoring:

• Active Bleeding Disorders: Clopivas 300 mg Tablet should not be used in patients with active bleeding, such as a bleeding stomach ulcer or bleeding inside the brain, as it may lead to serious or life-threatening bleeding.
• Severe Liver Disease: Liver impairment may affect how Clopivas 300 mg Tablet is converted into its active form and may increase the risk of bleeding complications.
• History of Stomach Ulcers or Gastrointestinal Bleeding: Patients with a history of stomach ulcers or digestive tract bleeding may have a higher risk of bleeding while taking this medicine.
• Recent Major Surgery or Trauma: Conditions associated with an increased risk of bleeding may require careful monitoring and assessment before treatment with Clopivas 300 mg Tablet.